AstraZeneca wins US approval for lymphoma drug

U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma.The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC's Calquence for ......